Skip to main content
TipRanks
Go Ultimate75% OFF

CStone Pharmaceuticals (2616) Income Statement

5 Followers

CStone Pharmaceuticals Income Statement

Last quarter (Q2 2026), CStone Pharmaceuticals's total revenue was ¥202.27M, a decrease of 20.42% from the same quarter last year. In Q2, CStone Pharmaceuticals's net income was ¥-248.80M. See CStone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 269.58M¥ 407.20M¥ 463.84M¥ 481.36M¥ 243.72M
¥ 51.25M¥ 240.15M¥ 304.30M¥ 278.38M¥ 136.89M
¥ 483.87M¥ 331.85M¥ 909.86M¥ 1.19B¥ 1.97B
Depreciation and Amortization¥ 43.98M¥ 49.80M¥ 58.19M¥ 44.54M¥ 22.66M
¥ -371.84M¥ -45.55M¥ -297.23M¥ -849.66M¥ -1.90B
¥ -432.62M¥ -91.69M¥ -605.57M¥ -912.15M¥ -1.83B
¥ 8.68M¥ 485.00K¥ 238.33M¥ 9.47M¥ -90.66M
¥ -423.94M¥ -91.21M¥ -367.23M¥ -902.68M¥ -1.92B
¥ -437.00M¥ -91.21M¥ -367.23M¥ -902.68M¥ -1.92B
Per Share Metrics
Basic EPS¥ -0.31¥ -0.07¥ -0.29¥ -0.77¥ -1.65
Diluted EPS¥ -0.31¥ -0.07¥ -0.29¥ -0.77¥ -1.65
Weighted Average Shares Outstanding1.39B1.28B1.26B1.17B1.16B
Weighted Average Shares Outstanding (Diluted)1.39B1.28B1.26B1.17B1.17B

Currency in CNY

CStone Pharmaceuticals Earnings and Revenue History

-3B-1.5B01.5B-15000 %-10000 %-5000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin